Myriad Genetics logo
Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.350
+0.200 (4.82%)
At close: Oct 15, 2026, 4:00 PM EDT
4.420
+0.070 (1.61%)
After-hours: Oct 15, 2026, 7:47 PM EDT

Myriad Genetics Revenue

Myriad Genetics had revenue of $190.70M in the quarter ending June 30, 2026, a decrease of -10.51%. This brings the company's revenue in the last twelve months to $806.60M, down -3.16% year-over-year. In the year 2025, Myriad Genetics had annual revenue of $824.50M, down -1.56%. That makes Myriad Genetics the 8,637th largest company in the world by revenue and 1,937th in the United States.

Revenue (ttm)
$806.60M
Revenue Growth
-3.16%
P/S Ratio
0.52
Revenue / Employee
$298,741
Employees
2,700
Market Cap
416.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025824.50M-13.10M-1.56%
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M52.00M8.14%
Jun 30, 2020638.60M-212.50M-24.97%
Jun 30, 2019851.10M107.40M14.44%
Jun 30, 2018743.70M15.00M2.06%
Jun 30, 2017728.70M-11.80M-1.59%
Jun 30, 2016740.50M17.40M2.41%
Jun 30, 2015723.10M-55.10M-7.08%
Jun 30, 2014778.20M165.00M26.91%
Jun 30, 2013613.20M117.20M23.63%
Jun 30, 2012496.01M93.92M23.36%
Jun 30, 2011402.08M39.44M10.87%
Jun 30, 2010362.65M36.12M11.06%
Jun 30, 2009326.53M103.67M46.52%
Jun 30, 2008222.86M77.57M53.39%
Jun 30, 2007145.29M31.01M27.13%
Jun 30, 2006114.28M31.87M38.68%
Jun 30, 200582.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
OPKO Health587.90M
GeneDx Holdings454.43M
Castle Biosciences357.28M
Fulgent Genetics323.93M
Biodesix102.94M
Burning Rock Biotech73.70M
Exagen71.12M
Personalis69.67M
Revenue Rankings